DuPont

For profitContributed to NMEWebsite ↗

Also known as: Dupont Applied Biosciences | DuPont Nutrition and Biosciences | DuPont Nutrition and Health | DuPont nutrition bioscience Aps

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 1994

First marketed drug

Apr 13, 1971

First NDA

Apr 13, 1971

Last known activity

Mar 1, 2020

Acquired by Bristol-Myers Squibb on Jan 1, 2001

Timeline

1800s

Jan 1, 1802
DuPont— Founded

1970s

Dec 28, 1979
molindone— NDA Secondary Org

1980s

Jan 1, 1981
New England Nuclear— Acquired

1990s

Jan 1, 1998
DuPont Merck— Acquired
Sep 17, 1998
efavirenz— NDA Organization

2000s

Jan 1, 2000
Algos Pharmaceutical Corp— Acquired
Jan 1, 2001
Bristol-Myers Squibb— Acquired By
Jan 1, 2008
Genencor— Acquired

2010s

Jan 9, 2011
Danisco— Acquired
May 1, 2012
Solae, LLC— Acquired

Drugs by trial phase (45 distinct, 68 trials)

Phase 4 (3 own, 4 via acquisition)

Phase 3 (1 own, 9 via acquisition)

Phase 2 (4 own, 10 via acquisition)

Phase 1 (0 own, 2 via acquisition)

Other trials (3 own, 9 via acquisition)

Marketed drugs (11)

Subsidiaries (6 direct, 6 total across the full acquisition tree)

Recent trials (22)

NCT04289883CollaboratorN/AMar 1, 2020
NCT03601559CollaboratorN/AAug 31, 2018
NCT03494725CollaboratorN/AApr 10, 2018
NCT02535962CollaboratorPhase 2Oct 1, 2016
NCT02314936CollaboratorPhase 2Apr 1, 2015
NCT02413710Lead sponsorN/AFeb 28, 2015
NCT02180841CollaboratorN/AMar 1, 2014
NCT01728610Study directorPhase 2Oct 1, 2012
NCT01728610Study chairPhase 2Oct 1, 2012
NCT01669603CollaboratorN/AAug 1, 2012
NCT01463293CollaboratorPhase 3Mar 1, 2012
NCT01400490CollaboratorN/ASep 1, 2010
NCT03072641CollaboratorN/AJun 3, 2010
NCT00988585CollaboratorPhase 1Apr 1, 2009
NCT00317031CollaboratorPhase 4Nov 1, 2002

Details

Founded: Wilmington, DE, US Jan 1, 1802
First NDA: Apr 13, 1971
Last known activity: Mar 1, 2020

Designations held

Fast track
Priority review
Accelerated approval